Table 1.
Patient Characteristics.
| Variable | N = 49 |
|---|---|
| Median Age | 59 (Range: 30–94) |
| Median of most recent HbA1C | 7.2 (Range: 5.4–14.3) |
| Median BMI | 33.9 (Range: 21.5–63.9) |
| Median duration of symptoms (days) | 22 (Range: 5–54) |
| Median time from initial screening call to COVID testing (days) | 1 (Range: 0–7) |
| Median duration of program enrollment (days) | 14 (Range: 1–31) |
| Median number of follow-up calls | 12 (Range: 1–37) |
| Gender | |
| Male | 13 (27%) |
| Female | 36 (73%) |
| Race | |
| White or Caucasian | 7 (14%) |
| Black or African American | 33 (67%) |
| Asian | 2 (4%) |
| Other | 7 (14%) |
| Initial Risk Tier Assignment | |
| Low Risk | 6 (12%) |
| Intermediate Risk | 25 (51%) |
| High Risk | 18 (37%) |
| Presence of Comorbidities | |
| Hypertension | 38 (78%) |
| Obesity (BMI > 30) | 31 (63%) |
| Renal disease | 8 (16%) |
| Lung disease | 11 (22%) |
| Cardiac disease | 7 (14%) |
| Eye disease | 2 (4%) |
| Smoking Status | |
| Active Smoker | 2 (4%) |
| Former Smoker | 9 (18%) |
| Never Smoker | 38 (78%) |
| Diabetes medications | |
| Insulin | 15 (31%) |
| Metformin | 39 (80%) |
| Other oral medications | 20 (41%) |
| Total number of active medications | |
| 0 | 1 (2%) |
| 1–4 | 9 (18%) |
| 5–8 | 21 (43%) |
| 9+ | 18 (37%) |
| Hypertensive Medications | |
| CCB | 24 (49%) |
| ACE-I | 14 (29%) |
| ARB | 16 (33%) |
| Beta blocker | 15 (31%) |
| Thiazide | 19 (39%) |
| Presenting Symptoms | |
| Cough | 40 (82%) |
| Fever | 27 (55%) |
| Loss of smell or taste | 23 (47%) |
| Chills | 23 (47%) |
| SOB with exertion | 23 (47%) |
| Body aches | 22 (45%) |
| Headache | 18 (37%) |
| Diarrhea | 18 (37%) |
| Sinus congestion | 15 (31%) |
| Sore throat | 15 (31%) |
| Chest tightness | 12 (24%) |
| Dizziness when standing | 11 (22%) |
| SOB at rest | 11 (22%) |
| Joint pain | 7 (14%) |
| Nausea | 7 (14%) |
| Anorexia | 4 (8%) |
| Hyperglycemia | 4 (8%) |
| Abdominal Pain | 4 (8%) |
| Confusion | 4 (8%) |
| Wheezing | 3 (6%) |
| Rash | 0 (0%) |
ACE-I: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; BMI: body mass index; CCB: calcium channel blocker; HbA1C: hemoglobin A1C; SOB: shortness of breath.